Mol Clin Oncol 13:[Related article:] Article no. 55, 2020; DOI:
10.3892/mco.2020.2125
Subsequently to the publication of this article, the
authors wish to change the information that is presented in
relation to the Research Ethics Committee and approval number for
their prospective study, which is no longer accurated as reported.
The final sentence in the ‘Study design’ subsection of the
Patients and methods, as featured on p. 2 [‘This prospective study
was reviewed about science and ethics and approved by the Research
Ethics Committee of Kawasaki Medical School and Hospital (approval
no. 240, UMIN000021797)]’ should be amended to the following:
‘This prospective study was reviewed for its science and ethics
and approved by the Certified Committee for Regenerative Medicine
of Kawasaki Medical School Hospital (Committee number, NB6150002;
protocol number, PC6150017; Japan Registry of Clinical Trials
[jRCT] number, jRCTc060190032’. Likewise, the first sentence in
the ‘Ethics approval and consent to participate’ section of
the Declarations on p. 7 should now read as follows: ‘The present
study was reviewed and approved by the Certified Committee for
Regenerative Medicine of Kawasaki Medical School Hospital
(Committee number, NB6150002; protocol number, PC6150017; Japan
Registry of Clinical Trials [jRCT] number, jRCTc060190032’.
The authors apologize to the readership of the
Journal for any inconvenience caused.
